journal article·2017-04-03Open access

Endovascular Embolization by Transcatheter Delivery of Particles: Past, Present, and Future

Rahul A. Sheth, Sharjeel Sabir, Savitri Krishnamurthy, Reginald K. Avery, Yu Shrike Zhang, Ali Khademhosseini, Rahmi Oklu

Abstract

Minimally invasive techniques to occlude flow within blood vessels, initially pioneered in the 1970s with autologous materials and subsequently advanced with increasingly sophisticated engineered biomaterials, are routinely performed for a variety of medical conditions. Contemporary interventional radiologists have at their disposal a wide armamentarium of occlusive agents to treat a range of disease processes through a small incision in the skin. In this review, we provide a historical perspective on endovascular embolization tools, summarize the current state-of-the-art, and highlight burgeoning technologies that promise to advance the field in the near future.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Vascular Anomalies and Treatments · Venous Thromboembolism Diagnosis and Management · Vascular Malformations Diagnosis and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Interventional Radiology, Division of Diagnostic Imaging, MD Anderson Cancer Center, Houston, TX 77030, USA

Department of Pathology, MD Anderson Cancer Center, Houston, TX 77030, USA

Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA

Biomaterials Innovation Research Center, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02139, USA

Division of Interventional Radiology, Mayo Clinic, 5777 E Mayo Blvd, Scottsdale AZ 85054, USA

References (30)

Show source-provided references
1. Therapeutic angiographic embolization10.1259/0007-1285-50-592-241 ↗
2. Vascular occlusive agents10.2214/ajr.136.1.151 ↗
3. Renal arteriovenous fistula treated by catheter embolization10.1259/0007-1285-46-543-222 ↗
4. Transfemoral catheter embolization of cerebral and posterior fossa arteriovenous malformations10.1148/103.1.107 ↗
5. Embolic agents used for uterine fibroid embolization10.2214/ajr.175.3.1750767 ↗
6. Therapeutic transcatheter arterial embolization10.1148/112.1.13 ↗
7. Facial palsy after glomus jugulare tumour embolization10.1017/S0022215100143762 ↗
8. Bladder necrosis secondary to pelvic artery embolization: Case report and literature review10.1016/S0022-5347(17)34969-8 ↗
9. Gelatine sponge particles: Handling characteristics for endovascular use10.1053/j.tvir.2008.03.002 ↗
10. Embolization agents-which one should be used when? Part 1: Large-vessel embolization10.1055/s-0029-1242206 ↗
11. Long term follow-up of transcatheter embolization with autologous clot, oxycel and gelfoam in domestic swine10.1097/00004424-197705000-00012 ↗
12. Transcatheter gelfoam embolization in abdominal, retroperitoneal, and pelvic hemorrhage10.1148/radiology.136.2.6967615 ↗
13. Buttock necrosis and paraplegia after bilateral internal iliac artery embolization for postpartum hemorrhage10.1097/AOG.0b013e31825699cc ↗
14. Pelvic abscess complicating embolic therapy for control of bleeding cervical carcinoma and simultaneous radiation therapy10.1097/00006250-198003001-00024 ↗
15. Arterial distribution characteristics of Embozene particles and comparison with other spherical embolic agents in the porcine acute embolization model10.1016/j.jvir.2009.08.018 ↗
16. Comparative in vitro evaluation of microspherical embolisation agents10.1007/s10856-006-0592-x ↗
17. Microspheres and nonspherical particles for embolization10.1053/j.tvir.2008.03.010 ↗
18. Current evidence on uterine embolization for fibroids10.1055/s-0033-1359727 ↗
19. Higher rate of partial devascularization and clinical failure after uterine artery embolization for fibroids with spherical polyvinyl alcohol10.1007/s00270-005-0243-5 ↗
20. Liang, B., Xiong, F., Wu, H., Wang, Y., Dong, X., Cheng, S., Feng, G.S., Zhou, G.F., Xiong, B., and Liang, H.M. (2013). Effect of transcatheter intraarterial therapies on the distribution of Doxorubicin in liver cancer in a rabbit model. PLoS ONE, 8.10.1371/journal.pone.0076388 ↗
21. Drug-eluting particles for interventional pharmacology10.1053/j.tvir.2008.03.003 ↗
22. Injectable biodegradable hydrogels10.1002/mabi.200900402 ↗
23. A novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses10.1016/j.ejvs.2012.10.008 ↗
24. Microfluidic fabrication of hydrogel microparticles containing functionalized viral nanotemplates10.1021/la102446n ↗
25. Histological interaction of cultured endothelial cells and endovascular embolic materials coated with extracellular matrix10.3171/jns.1997.86.1.0109 ↗
26. Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator10.1016/j.carbpol.2010.11.052 ↗
27. Haemostatic activity of ethamsylate and aminocaproic acid adsorbed poly(2-hydroxyethyl methacrylate) particles10.1016/0142-9612(92)90103-U ↗
28. New acrylic microspheres for arterial embolization: Combining radiopacity for precise localization with immobilized thrombin to trigger local blood coagulation10.1016/j.biomaterials.2006.12.031 ↗
29. Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery10.1002/smll.200801855 ↗
30. Synthesis of monodisperse biodegradable microgels in microfluidic devices10.1021/la051527y ↗